TerminatedNot Applicable

Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin

Stopped: Unable to recruit participants due to rare disease

United States1 participantsStarted 2022-10-31

Plain-language summary

This study evaluates the accuracy of a new ultrasound technology called microvessel imaging for detecting the extent of disease among patients with angiosarcoma of the skin. Microvessel ultrasound imaging uses high frequency waves to visualize vessels in the skin that are not easily seen using other imaging tests.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Diagnosed with cutaneous angiosarcoma of the breast or scalp and scheduled for trimodality therapy * Twenty one years of age or older Exclusion Criteria: * Unwilling to consent to microvessel ultrasound imaging * Younger than 21 years of age

What they're measuring

Accuracy of microvessel ultrasound imaging

Timeframe: Through to study completion up to one year

Trial details

NCT IDNCT05729425

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-15

View on ClinicalTrials.gov More Skin Angiosarcoma trials